Gabriele Amari

CHF6001 I: A Novel Highly Potent and Selective Phosphodiesterase 4 Inhibitor with Robust Anti-Inflammatory Activity and Suitable for Topical Pulmonary Administration

Nadia Moretto, Paola Caruso, Raffaella Bosco et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 72 citations

Novel Class of Benzoic Acid Ester Derivatives as Potent PDE4 Inhibitors for Inhaled Administration in the Treatment of Respiratory Diseases

Elisabetta Armani, Gabriele Amari, Andrea Rizzi et al. · Journal of Medicinal Chemistry · 2014 · 47 citations · Full text

Asthma, Pharmaceutical Science, Inflammatory Lung Disease +19

Structural Determinants of<i>Torpedo</i><i>c</i><i>alifornica</i>Acetylcholinesterase Inhibition by the Novel and Orally Active Carbamate Based Anti-Alzheimer Drug Ganstigmine (CHF-2819)

Cecilia Bartolucci, Mariacristina Siotto, Eleonora Ghidini et al. · Journal of Medicinal Chemistry · 2006 · 44 citations · Full text

Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor Antagonist

G. Villetti, Francesco Saverio Pastore, M. Bergamaschi et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 28 citations

Discovery of Diaryl Imidazolidin-2-one Derivatives, a Novel Class of Muscarinic M3 Selective Antagonists (Part 1)

Ilaria Peretto, Roberto Forlani, Claudia Fossati et al. · Journal of Medicinal Chemistry · 2007 · 24 citations · Full text

Medicinal Chemistry, Part 1, Biochemistry +15